Previous Close | 48.86 |
Open | 47.39 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1400 |
Day's Range | 44.37 - 47.50 |
52 Week Range | 44.37 - 69.10 |
Volume | |
Avg. Volume | 16,008,464 |
Market Cap | 90.596B |
Beta (5Y Monthly) | 0.39 |
PE Ratio (TTM) | 11.58 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.40 (4.91%) |
Ex-Dividend Date | Apr 04, 2024 |
1y Target Est | N/A |
PRINCETON, N.J., April 25, 2024--Bristol Myers Squibb Reports First Quarter Financial Results for 2024
PRINCETON, N.J. & SOUTH SAN FRANCISCO, Calif., April 22, 2024--Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies....
NORTHAMPTON, MA / ACCESSWIRE / April 11, 2024 / Bristol Myers Squibb Company: At Bristol Myers Squibb, our vision is to transform patients' lives through science Originally published on Bristol Myers Squibb News & Perspectives Since 1887, BMS has ...